Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig S Barr

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|September 8, 2012
Recurrent Candida parapsilosis infective endocarditis aortic root replacementAhmed A Gilani, Craig S Barr
Circulation. Arrhythmia and Electrophysiology|July 8, 2015
Longevity of the Subcutaneous Implantable Defibrillator: Long-Term Follow-Up of the European Regulatory Trial CohortDominic A M J Theuns, Ian G Crozier, Craig S Barr, et al.
Heart Rhythm|November 29, 2016
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indicationLucas V Boersma, Craig S Barr, Martin C Burke, et al.
Journal of the American College of Cardiology|April 25, 2015
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS RegistryMartin C Burke, Michael R Gold, Bradley P Knight, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2015
The learning curve associated with the introduction of the subcutaneous implantable defibrillatorReinoud E Knops, Tom F Brouwer, Craig S Barr, et al.
Circulation|October 19, 2020
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) TrialMichael R Gold, Pier D Lambiase, Mikhael F El-Chami, et al.
Heart Rhythm|May 15, 2019
Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative resultsLucas V Boersma, Mikhael F El-Chami, Maria Grazia Bongiorni, et al.
The New England Journal of Medicine|May 14, 2010
An entirely subcutaneous implantable cardioverter-defibrillatorGust H Bardy, Warren M Smith, Margaret A Hood, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
British Journal of Hospital Medicine (London, England : 2005)|September 8, 2012
Recurrent Candida parapsilosis infective endocarditis aortic root replacementAhmed A Gilani, Craig S Barr
Circulation. Arrhythmia and Electrophysiology|July 8, 2015
Longevity of the Subcutaneous Implantable Defibrillator: Long-Term Follow-Up of the European Regulatory Trial CohortDominic A M J Theuns, Ian G Crozier, Craig S Barr, et al.
Heart Rhythm|November 29, 2016
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indicationLucas V Boersma, Craig S Barr, Martin C Burke, et al.
Journal of the American College of Cardiology|April 25, 2015
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS RegistryMartin C Burke, Michael R Gold, Bradley P Knight, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2015
The learning curve associated with the introduction of the subcutaneous implantable defibrillatorReinoud E Knops, Tom F Brouwer, Craig S Barr, et al.
Circulation|October 19, 2020
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) TrialMichael R Gold, Pier D Lambiase, Mikhael F El-Chami, et al.
Heart Rhythm|May 15, 2019
Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative resultsLucas V Boersma, Mikhael F El-Chami, Maria Grazia Bongiorni, et al.
The New England Journal of Medicine|May 14, 2010
An entirely subcutaneous implantable cardioverter-defibrillatorGust H Bardy, Warren M Smith, Margaret A Hood, et al.
Pageof 1